Core Insights - The animal health sector experienced a decline of 0.24% on November 17, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers included: - Qudongli (code: 920275) with a closing price of 10.68, up 5.12% [1] - *ST Lvkang (code: 002868) with a closing price of 42.57, up 5.01% [1] - Houfeng Holdings (code: 002141) with a closing price of 3.91, up 2.62% [1] - Major decliners included: - Dayu Biological (code: 920970) with a closing price of 8.70, down 3.87% [2] - Ruipu Biological (code: 300119) with a closing price of 20.61, down 2.92% [2] - Zhongmu Co., Ltd. (code: 600195) with a closing price of 7.94, down 1.98% [2] Capital Flow - The animal health sector saw a net outflow of 10.15 million yuan from institutional investors, while retail investors experienced a net outflow of 20.76 million yuan [2] - Conversely, speculative funds recorded a net inflow of 30.91 million yuan [2] Individual Stock Capital Flow - Notable capital flows included: - Biological Shares (code: 600201) with a net inflow of 12.08 million yuan from institutional investors [3] - Xianfeng Holdings (code: 002141) with a net inflow of 9.50 million yuan from institutional investors [3] - Ruipu Biological (code: 300119) with a net inflow of 1.05 million yuan from speculative funds [3] - Decliners in capital flow included: - *ST Lvkang (code: 002868) with a net outflow of 0.79 million yuan from institutional investors [3] - Hai Li Biological (code: 603718) with a net outflow of 2.82 million yuan from institutional investors [3]

Core Viewpoint - The animal health sector experienced a slight increase of 0.89% on November 14, with *ST Green Kang leading the gains, while the overall market indices, including the Shanghai Composite Index and Shenzhen Component Index, saw declines of 0.97% and 1.93% respectively [1] Group 1: Market Performance - The closing price of *ST Green Kang was 40.54, reflecting a rise of 5.00% with a trading volume of 204,000 shares and a transaction value of 8.27 million yuan [1] - Other notable performers included Ruipu Biology with a closing price of 21.23, up 1.87%, and Biological Shares at 11.93, up 1.62% [1] - The overall trading volume and transaction values for various companies in the animal health sector were significant, with Biological Shares recording a transaction value of 954 million yuan [1] Group 2: Capital Flow - The animal health sector saw a net outflow of 57.68 million yuan from institutional investors, while retail investors contributed a net inflow of 60.01 million yuan [2] - The capital flow data indicates that *ST Green Kang had a net inflow of 1.42 million yuan from institutional investors, despite a net outflow from retail investors [3] - Other companies like Biological Shares and Ruipu Biology experienced significant net outflows from institutional investors, indicating a shift in investment sentiment [3]

证券代码：688098 证券简称：申联生物 公告编号：2025-039 申联生物医药(上海)股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 12 月 1 日（星期一）16:00-17:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络文字互动 一、说明会类型 本次投资者说明会以网络文字互动形式召开，公司将针对 2025 年第三季度的经营成果及财务指标的具体情况与投资者进行互动交 流和沟通，在信息披露允许的范围内就投资者普遍关注的问题进行回 答。 二、说明会召开的时间、地点 （一）会议召开时间：2025 年 12 月 1 日（星期一）16:00-17:00 （二）会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 投资者可于 2025 年 11 月 24 日（星期一）至 ...

Core Insights - The animal health sector experienced a slight increase of 0.14% on November 12, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance Summary - *ST Lvkang (002868) closed at 36.77, up 5.00% with a trading volume of 62,400 shares and a transaction value of 226 million [1] - Other notable performers included: - Qudongli (920275) at 10.76, up 3.86% [1] - Yongshun Biological (920729) at 10.15, up 1.81% [1] - Biological Shares (600201) at 10.76, up 1.22% [1] - Zhongmu Shares (600195) at 7.98, up 0.50% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 35.94 million from institutional investors, while retail investors contributed a net inflow of 20.57 million [2] - The capital flow for individual stocks showed: - KQ Bio (688526) had a net inflow of 7.99 million from institutional investors [3] - Biological Shares (600201) had a net inflow of 6.25 million from institutional investors [3] - However, KQ Bio (688526) also experienced a net outflow of 16.05 million from retail investors [3]

Core Insights - The animal health sector experienced a slight increase of 0.55% on November 7, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - *ST Lvkang (002868) closed at 31.76, up 4.99% with a trading volume of 12,000 hands and a transaction value of 37.6483 million yuan [1] - Other notable stocks included: - Biological Shares (600201) at 10.52, up 1.64% with a trading volume of 234,300 hands [1] - Driving Force (920275) at 9.88, up 1.13% with a trading volume of 7,484 hands [1] - Zhongmu Shares (600195) at 7.75, up 0.65% with a trading volume of 77,200 hands [1] Capital Flow - The animal health sector saw a net outflow of 5.144 million yuan from institutional investors, while retail investors experienced a net outflow of 11.0652 million yuan [2] - Conversely, speculative funds recorded a net inflow of 16.2092 million yuan [2] Detailed Capital Flow Analysis - Major stocks and their capital flow included: - Biological Shares (600201) with a net inflow of 20.3753 million yuan from institutional investors [3] - *ST Lvkang (002868) had a net inflow of 2.9042 million yuan from institutional investors [3] - Huisheng Biological (300871) faced a significant net outflow of 18.6925 million yuan from institutional investors [3]

Core Insights - The animal health sector experienced a decline of 0.35% on November 3, with Reap Bio leading the losses [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance Summary - Hai Li Biological (603718) closed at 7.02, up 2.03% with a trading volume of 101,600 shares and a turnover of 70.93 million yuan [1] - Shen Lian Biological (688098) closed at 11.36, up 1.43% with a trading volume of 133,100 shares and a turnover of 150 million yuan [1] - Yong Shun Biological (920729) closed at 10.09, up 1.00% with a trading volume of 23,800 shares and a turnover of 24.09 million yuan [1] - The worst performer was Reap Bio (300119), which closed at 21.01, down 2.51% with a trading volume of 103,300 shares and a turnover of 219 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 35.26 million yuan from institutional investors, while retail investors had a net inflow of 26.79 million yuan [2] - The main capital inflow was observed in Shen Lian Biological, with a net inflow of 4.03 million yuan from institutional investors [3] - Conversely, Reap Bio experienced a net outflow of 1.29 million yuan from institutional investors [3]

Core Viewpoint - The animal health sector experienced a rise of 1.53% on October 31, with Shunlian Biological leading the gains, while the overall market indices, Shanghai Composite and Shenzhen Component, saw declines of 0.81% and 1.14% respectively [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3954.79, down 0.81% [1] - The Shenzhen Component Index closed at 13378.21, down 1.14% [1] - The animal health sector stocks showed varied performance, with Shunlian Biological rising by 9.38% to a closing price of 11.20 [1] Group 2: Stock Performance - Shunlian Biological (688098) led the sector with a closing price of 11.20 and a trading volume of 193,300 shares, amounting to a transaction value of 211 million [1] - Other notable stocks included *ST Lvkang (002868) with a 1.61% increase, closing at 28.44, and Dayu Biological (920970) with a 1.38% increase, closing at 9.53 [1] - The overall trading volume for the animal health sector was significant, with Shunlian Biological contributing 211 million and other stocks like Biological Shares (600201) contributing 283 million [1] Group 3: Fund Flow Analysis - The animal health sector saw a net outflow of 19.81 million from institutional investors and 14.34 million from retail investors, while individual investors contributed a net inflow of 34.15 million [1] - Specific stock fund flows indicated that Biological Shares (600201) had a net inflow of 10.32 million from institutional investors, while Shunlian Biological experienced a net outflow of 12.41 million from retail investors [2] - The overall sentiment in the sector showed mixed results, with some stocks like Biological Shares attracting institutional interest despite overall net outflows [2]

Core Viewpoint - Shenyuan Biological is a leading enterprise in the field of veterinary synthetic peptide vaccines in China, with a focus on research, production, and sales of veterinary biological products [1] Group 1: Business Performance - In Q3 2025, Shenyuan Biological reported revenue of 238 million yuan, ranking 10th in the industry, significantly lower than the top company, Zhongmu Co., which had 4.442 billion yuan, and the second, Ruipu Biological, with 2.544 billion yuan [2] - The net profit for the same period was -3.0229 million yuan, placing the company 12th in the industry, far behind Ruipu Biological's 391 million yuan and KQ Biological's 337 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Shenyuan Biological's debt-to-asset ratio was 8.94%, an increase from 6.72% year-on-year, but still below the industry average of 28.36% [3] - The gross profit margin for Q3 2025 was 59.49%, down from 61.12% year-on-year, yet higher than the industry average of 40.13% [3] Group 3: Executive Compensation - The chairman, Nie Dongsheng, received a salary of 1.1286 million yuan in 2024, a decrease of 49,000 yuan from 2023 [4] - The general manager, Zhang Zhen, had a salary of 990,000 yuan in 2024, an increase of 46,000 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 30.87% to 12,400, while the average number of circulating A-shares held per account decreased by 23.59% to 33,100 [5]

Market Overview - The animal health sector experienced a decline of 2.79% on October 30, with Jinhe Biology leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Individual Stock Performance - Jinhe Biology (002688) closed at 6.25, down 7.13% with a trading volume of 578,000 shares and a transaction value of 367 million yuan [1] - Keqian Biology (688526) closed at 16.15, down 6.76% with a trading volume of 139,800 shares and a transaction value of 228 million yuan [1] - Maofeng Holdings (002141) closed at 3.92, down 5.08% with a trading volume of 461,300 shares and a transaction value of 18.3 million yuan [1] - Other notable declines include Dayu Biology (920970) down 2.69%, and Pulaike (603566) down 2.68% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 84.7 million yuan from institutional investors, while retail investors experienced a net outflow of 16.5 million yuan [1] - Speculative funds recorded a net inflow of 101 million yuan [1] Detailed Capital Flow for Selected Stocks - Keqian Biology (688526) had a net inflow of 39.6 million yuan from institutional investors, while retail investors saw a net outflow of 60.9 million yuan [2] - Huisheng Biology (300871) experienced a net inflow of 18.3 million yuan from institutional investors, with a net outflow of 21.2 million yuan from retail investors [2] - Other stocks like Pulaike (603566) and Maofeng Holdings (002141) also reported significant net outflows from institutional investors [2]

Core Insights - The animal health sector experienced a decline of 0.47% on October 28, with Shenyuan Biological leading the drop [1][2] - The Shanghai Composite Index closed at 3988.22, down 0.22%, while the Shenzhen Component Index closed at 13430.1, down 0.44% [1] Stock Performance - Zhongmu Co., Ltd. (600195) saw a closing price of 7.78, with an increase of 4.71% and a trading volume of 346,700 shares, amounting to a transaction value of 269 million yuan [1] - Xianfeng Holdings (002141) closed at 4.16, up 2.72%, with a trading volume of 394,400 shares [1] - Ruipu Biological (300119) closed at 21.55, up 1.03%, with a trading volume of 127,300 shares [1] - Shenyuan Biological (688098) closed at 10.30, down 6.36%, with a trading volume of 168,900 shares and a transaction value of 176 million yuan [2] - Biological Shares (600201) closed at 10.63, down 4.06%, with a trading volume of 380,700 shares [2] Capital Flow - The animal health sector saw a net outflow of 81.39 million yuan from institutional investors, while retail investors had a net inflow of 71.62 million yuan [2][3] - The capital flow for individual stocks showed that Ruipu Biological had a net inflow of 15.04 million yuan from institutional investors, while it faced a net outflow of 25.78 million yuan from retail investors [3] - Shenyuan Biological experienced a net outflow of 5.53 million yuan from institutional investors, with a net inflow of 6.62 million yuan from retail investors [3]